[Federal Register Volume 65, Number 186 (Monday, September 25, 2000)]
[Notices]
[Pages 57628-57629]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-24577]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Advisory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on November 8-9, 2000. The meeting will take place at the 
address provided below. Topics of discussion will include: (1) The 
status of the rulemaking of 10 CFR part 35, ``Medical Use of Byproduct 
Material''; (2) the implementation plan for Part 35; and (3) issues 
concerning intravascular brachytherapy. An update of other rulemaking 
activities will be provided. The ACMUI will also discuss: (1) The 
criteria for ACMUI self-evaluation; (2) NRC's Strategic Plan; and (3) 
the planning, budget, and performance measures process. All sessions of 
the meeting will be open to the public, with the exception of the first 
session, which will be closed to provide required Annual Ethics 
Training for ACMUI committee members and to discuss information that, 
if released for public view, would constitute a clearly unwarranted 
invasion of personal privacy.

DATES: The November 8, 2000, meeting will be held from 9 a.m. to 5 
p.m., to accommodate Annual Ethics Training for members from 8 to 9 
a.m. The November 9, 2000, meeting will be held from 8 a.m. to 12 p.m.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North 
Auditorium, 11545 Rockville Pike, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION, CONTACT: Betty Ann Torres, telephone (301) 
415-0191, e-mail <a href="/cdn-cgi/l/email-protection#6f0d0e1b2f011d0c41080019"><span class="__cf_email__" data-cfemail="33515247735d41501d545c45">[email protected]</span></a>, of the Office of Nuclear Material Safety 
and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001.

Conduct of the Meeting

    Manuel D. Cerqueira, M.D., will chair the meeting. Dr. Cerqueira 
will conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit 
reproducible copy to Betty Ann Torres (address previously listed), by 
November 1, 2000. Statements must

[[Page 57629]]

pertain to the topics on the agenda for the meeting.
    2. Questions from members of the public will be permitted, during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
11555 Rockville Pike, Rockville, MD 20852-27382, telephone (800) 397-
4209, on or about December 6, 2000. Minutes of the meeting will be 
available on or about January 8, 2000.
    4. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: September 19, 2000.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 00-24577 Filed 9-22-00; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>